Ergocalciferol and Epidiolex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Epidiolex (cannabidiol). Common drug interactions include pneumatosis among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Epidiolex. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

What is Epidiolex?

Epidiolex has active ingredients of cannabidiol. eHealthMe is studying from 18,763 Epidiolex users. Check the latest studies of Epidiolex.

On Jul, 15, 2026

30 people who take Ergocalciferol and Epidiolex together, and have interactions are studied.

Ergocalciferol and Epidiolex drug interactions.

What are the common drug interactions of Ergocalciferol and Epidiolex, by gender? *:

female:

Pneumatosis (air or gas in an abnormal location in the body)
Hospitalisation
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

male:

Acute respiratory failure
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Death
Cardiac arrest
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
Hypotension (abnormally low blood pressure)
Lactic acidosis (low ph in body tissues)
Nephrolithiasis (calculi in the kidneys)
Pulse absent

What are the common drug interactions of Ergocalciferol and Epidiolex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Acute respiratory failure
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Pyrexia (fever)
Respiratory tract infection
Biliary tract disorder
Gastritis (inflammation of stomach)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiration (transport of oxygen from the outside air to the cells within tissues)
Urinary tract infection
Viral infection

10-19:

Pneumatosis (air or gas in an abnormal location in the body)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

20-29:

Spinal fracture (fracture in one of vertebrae)
Cataplexy (loss of muscle tone accompanied by full conscious awareness)
Diarrhoea
Insomnia (sleeplessness)
Rash
Seasonal allergy (allergic condition due to certain season)

30-39:

Diarrhoea
Optic neuropathy (optic nerve damage)
Seasonal allergy (allergic condition due to certain season)
Spinal fracture (fracture in one of vertebrae)
Visual field defect

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 13 people, 43.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 26.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 7 people, 23.33%
Seizure Cluster (small group of seizure): 3 people, 10.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 10.00%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 6.67%
Pain: 2 people, 6.67%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 6.67%
Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ergocalciferol and Epidiolex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously